Is there a benefit of ICD treatment in patients with persistent severely reduced systolic left ventricular function after TAVI?
Richard J NiesChristian FrerkerMatti AdamElmar KuhnVictor MauriFelix S NettersheimSimon BraumannThorsten WahlersStephan BaldusTobias SchmidtPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2021)
In high-risk TAVI-patients suffering from heart failure with LVEF ≤ 35%, LVEF improvement to more than 35% did not reduce overall mortality. Patients with postprocedural persistent LVEF reduction did not seem to benefit from ICD treatment. Effects of LVEF improvement and ICD treatment on mortality are masked by the competing risk of death from relevant comorbidities.
Keyphrases
- heart failure
- left ventricular
- end stage renal disease
- chronic kidney disease
- aortic valve
- transcatheter aortic valve implantation
- blood pressure
- aortic stenosis
- coronary artery disease
- combination therapy
- prognostic factors
- atrial fibrillation
- acute myocardial infarction
- hypertrophic cardiomyopathy
- acute coronary syndrome
- patient reported